TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Gross Profit 2020–2025
TG Therapeutics, Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- TG Therapeutics, Inc. gross profit for the quarter ending March 31, 2026 was 171.4 M, a 62.76% increase year-over-year.
- TG Therapeutics, Inc. gross profit for the twelve months ending March 31, 2026 was 581.7 M.
- TG Therapeutics, Inc. annual gross profit for 2025 was 515.6 M, a 77.47% increase from 2024.
- TG Therapeutics, Inc. annual gross profit for 2024 was 290.5 M, a 32.34% increase from 2023.
- TG Therapeutics, Inc. annual gross profit for 2023 was 219.5 M, a 8611.55% increase from 2022.
- TG Therapeutics, Inc. annual gross profit for 2022 was 2.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TG Therapeutics, Inc. Gross Profit — FAQ
TG Therapeutics, Inc. (TGTX) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is TG Therapeutics, Inc.'s gross profit?
TG Therapeutics, Inc. (TGTX) reported gross profit of $516M for fiscal 2025.
Where can I see TGTX's gross profit history?
The chart and table above show TG Therapeutics, Inc.'s gross profit by year and by quarter, including the growth rate.